In a case with an original diagnosis as DLBCL transformed from FL (case 5), GPM offered distinct advantages by simultaneously identifying PAX5::MYC and IGH::BCL2 rearrangements, along with additional CNAs including 11q aberrations and TP53 deletion. This evidence concerns the gene PAX5 and diffuse large B-cell lymphoma.